
Intuitive Surgical, Inc.
Intuitive Surgical
Intuitive Surgical, Inc. is the global pioneer and dominant leader in robotic-assisted minimally invasive surgery, founded in 1995 in Sunnyvale, California, United States. The company designs, manufactures, and markets the da Vinci surgical system — the most widely adopted robotic surgical platform in the world — alongside a growing ecosystem of instruments, digital solutions, and the Ion endoluminal platform for robotic-assisted bronchoscopy. The company's comprehensive portfolio encompasses the da Vinci Xi multi-port system, the da Vinci SP single-port system, the Ion robotic bronchoscopy platform for minimally invasive lung biopsy, a vast library of EndoWrist articulated instruments, integrated stapling and energy devices, and the My Intuitive digital surgery ecosystem including Intuitive Hub, Case Insights, and SimNow simulation training. With annual revenue of US$10.06 billion, Intuitive Surgical operates manufacturing facilities primarily in Sunnyvale, California and multiple international locations, employing approximately 17,000 employees serving 85+ countries. The company's installed base exceeds 10,000 da Vinci systems worldwide, and surgeons have performed over 17 million procedures using its platforms, creating an exceptionally durable razor-and-blade business model powered by recurring instrument and accessory revenue.
Strengths: Unassailable market position with over 80% global share in robotic-assisted surgery and an installed base exceeding 10,000 systems — a scale virtually impossible to replicate. Razor-and-blade business model generating approximately 75% recurring revenue from instruments and accessories, creating extreme earnings visibility. Massive clinical evidence moat with over 41,000 peer-reviewed publications validating da Vinci outcomes across dozens of surgical specialties. Deepening procedure penetration with annual procedure growth consistently exceeding 15%, driven by expansion into general surgery, hernia repair, and international markets. Ion platform emergence as a high-growth second franchise in robotic bronchoscopy with limited competition.
Weaknesses: Capital equipment cycle sensitivity with system placements vulnerable to hospital budget constraints and interest rate environments. Emerging competition from Medtronic, Johnson & Johnson, and numerous Chinese entrants (Kangduo, Toumai) that could compress pricing over time. Procedure concentration risk with a significant portion of growth dependent on continued expansion in general surgery and international markets.Read More ▼Show Less ▲
Strengths: Unassailable market position with over 80% global share in robotic-assisted surgery and an installed base exceeding 10,000 systems — a scale virtually impossible to replicate. Razor-and-blade business model generating approximately 75% recurring revenue from instruments and accessories, creating extreme earnings visibility. Massive clinical evidence moat with over 41,000 peer-reviewed publications validating da Vinci outcomes across dozens of surgical specialties. Deepening procedure penetration with annual procedure growth consistently exceeding 15%, driven by expansion into general surgery, hernia repair, and international markets. Ion platform emergence as a high-growth second franchise in robotic bronchoscopy with limited competition.
Weaknesses: Capital equipment cycle sensitivity with system placements vulnerable to hospital budget constraints and interest rate environments. Emerging competition from Medtronic, Johnson & Johnson, and numerous Chinese entrants (Kangduo, Toumai) that could compress pricing over time. Procedure concentration risk with a significant portion of growth dependent on continued expansion in general surgery and international markets.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Sunnyvale, California, United States
Founded
1995
Employees
17,021
Factories
Manufacturing operations in Sunnyvale, California and multiple international locations
Listing
Nasdaq: ISRGCategories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website Nasdaq: ISRG , Data Sources & Methodology
Intuitive Surgical Official Website
Intuitive Surgical - Wikipedia
Intuitive Surgical Investor Relations
Intuitive Surgical Revenue - Macrotrends
Intuitive Surgical Press Releases
